General Surgery Devices are used in diagnostic and surgical interventions primarily for the gastrointestinal tract, abdomen, and pelvis. Biopsy entails the removal of some tissue from the body for the purpose of diagnosis or for its examination under a microscope. GlobalData uses proprietary data and analytics to provide a comprehensive report on the biopsy devices market in New Zealand. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the biopsy devices market in New Zealand was Becton Dickinson and Co followed by Boston Scientific, Olympus, Argon Medical Devices, Hologic, Medtronic, Cook Medical, Merit Medical Systems, Integra LifeSciences, Teleflex, ConMed and Henry Schein.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
A Biopsy Device is an instrument that aids in the removal of tissue samples from the body. Biopsy Guns, Vacuum-Assisted Needle Devices, Biopsy Forceps, Biopsy Punches and Biopsy Needles are covered under Biopsy Device. Biopsy Needles are needles used to sample small amounts of tissues from the body. Vacuum-Assisted Needle Devices use a vacuum-powered system that aspirates several tissue samples rather than relying on the spring-loading mechanism seen in biopsy guns. Biopsy Forceps are used in association with an endoscope to obtain biopsy samples. Biopsy Guns are handheld spring-loaded devices with core needles attached. Biopsy Punches have a small circular blade attached to a handle which is rotated and moved down the layers of the tissue especially the skin to obtain a cylindrical tissue sample.
The biopsy devices market in New Zealand can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size biopsy devices in New Zealand, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
